Alpine Global Management’s Eiger BioPharmaceuticals, Inc. EIGR Stock Holding History
Bought
Maintained
Sold
Other funds holding EIGR
6CM
SAM
UOC
Alpine Global Management's EIGR Position: Q1 2023 in Review
Alpine Global Management sold out of Eiger BioPharmaceuticals, Inc. (EIGR) in Q1 2023, closing a stake of 2,064 shares — an estimated $73K sold.
Alpine Global Management first reported a position in EIGR in Q4 2018 and held it in 2 quarters. The position peaked at $126K in Q4 2018. 71 funds tracked by Wall St. Rank hold EIGR as of Q1 2023.
- Alpine Global Management reported no remaining Eiger BioPharmaceuticals, Inc. position as of Q1 2023 after selling out during the quarter.
- Alpine Global Management sold 2,064 Eiger BioPharmaceuticals, Inc. shares in Q1 2023, an estimated $73K.
- Alpine Global Management first reported a position in Eiger BioPharmaceuticals, Inc. in Q4 2018 and held it in 2 quarters.
- Alpine Global Management's Eiger BioPharmaceuticals, Inc. position peaked at $126K in Q4 2018.
- 71 funds tracked by Wall St. Rank held Eiger BioPharmaceuticals, Inc. as of Q1 2023.
Based on Alpine Global Management's 13F filing for Q1 2023, filed 15 May 2023.